Historically, anaplastic thyroid cancer (ATC) has been one of the most aggressive and challenging forms of cancer to treat, with traditional methods often resulting in poor survival rates. Treatment has remained a significant struggle, causing dismay for both patients and healthcare providers.
The notable progress and potential future of cellular therapy for solid tumors seen throughout 2024 signify a transformational year in oncology. The general sentiment within the oncology community is optimistic, particularly with the U.S. Food and Drug Administration's approval of the first
In a groundbreaking development, scientists have devised an innovative method for evaluating the oxygen delivery effectiveness of red blood cells (RBCs) by analyzing their shape. This advancement holds the potential to significantly enhance practices in transplant and transfusion medicine, as well
The field of prostate cancer treatment has seen significant advances with the introduction of novel therapies aimed at enhancing patient outcomes. One such promising advancement is the use of gozetotide for the accurate detection of PSMA-positive prostate cancer. This breakthrough is particularly
The digital health landscape in 2024 has been marked by unexpected developments, rapid advancements, and new challenges. Industry executives have reflected on the year's most surprising and impactful occurrences, providing insights into the evolving dynamics of healthcare technology. This article
The fight against hepatocellular carcinoma (HCC) has seen a significant breakthrough with the release of new findings from the NRG-RTOG 1112 Phase III clinical study. This study explored the effects of adding stereotactic body radiotherapy (SBRT) to the existing systemic therapy with sorafenib for
